Author:
Wong Chi Chun,Qian Yun,Li Xiaona,Xu Jiaying,Kang Wei,Tong Joanna H.,To Ka-Fai,Jin Ye,Li Weilin,Chen Huarong,Go Minnie Y.Y.,Wu Jian-Lin,Cheng Ka Wing,Ng Simon S.M.,Sung Joseph J.Y.,Cai Zongwei,Yu Jun
Subject
Gastroenterology,Hepatology
Reference35 articles.
1. Colorectal cancer statistics, 2014;Siegel;CA Cancer J Clin,2014
2. Cancer statistics, 2014;Siegel;CA Cancer J Clin,2014
3. Wild-type KRAS is required for panitumumab efficacy in patients with metastatic colorectal cancer;Amado;J Clin Oncol,2008
4. Effects of KRAS, BRAF, NRAS, and PIK3CA mutations on the efficacy of cetuximab plus chemotherapy in chemotherapy-refractory metastatic colorectal cancer: a retrospective consortium analysis;De Roock;Lancet Oncol,2010
5. KRAS, BRAF, PIK3CA, and PTEN mutations: implications for targeted therapies in metastatic colorectal cancer;De Roock;Lancet Oncol,2011
Cited by
99 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献